Advertisement

The Scientist

» biotech and developmental biology

Most Recent

image: Neural Target for Autism?

Neural Target for Autism?

By | February 7, 2014

Mouse and rat models of the developmental disorder responded positively to a drug given to their mothers a day before birth.

0 Comments

image: New Year’s Biotech IPO Boom?

New Year’s Biotech IPO Boom?

By | February 3, 2014

January was a profitable month for biotech companies going public, Burrill & Company says.

5 Comments

image: Meiosis Maven

Meiosis Maven

By | February 1, 2014

Fueled by her love of visual data and addicted to chromosomes, Abby Dernburg continues to study how homologous chromosomes find each other during gamete formation.

1 Comment

image: Unmasking Secret Identities

Unmasking Secret Identities

By | February 1, 2014

A tour of techniques for measuring DNA hydroxymethylation

2 Comments

image: Fish of Many Colors

Fish of Many Colors

By | January 23, 2014

Researchers seek insight into the pigmentation patterns of guppies and zebrafish.

0 Comments

image: Week in Review: January 6–10

Week in Review: January 6–10

By | January 10, 2014

Bacterial genes aid tubeworm settling; pigmentation of ancient reptiles; nascent neurons and vertebrate development; exploring simple synapses; slug-inspired surgical glue

0 Comments

image: Thomas Gregor: Biological Quantifier

Thomas Gregor: Biological Quantifier

By | November 1, 2013

Assistant Professor, Physics, Princeton University. Age: 39

0 Comments

image: Penetrating the Brain

Penetrating the Brain

By | November 1, 2013

Researchers use molecular keys, chisels, and crowbars to open the last great biochemical barricade in the body—the blood-brain barrier.

2 Comments

image: About Face

About Face

By | October 25, 2013

Researchers show that genetic enhancer elements likely contribute to face shape in mice.

0 Comments

image: Geron’s Stem Cell Program Sold

Geron’s Stem Cell Program Sold

By | October 2, 2013

The company, which launched the first ever clinical trial for a human embryonic stem cell therapy before shuttering its stem cell arm, has finally struck a deal with BioTime.

0 Comments

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Advertisement
The Scientist